Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NTRA Natera, Inc. daily Stock Chart
NTRA [NASD]
Natera, Inc.
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E- EPS (ttm)-2.02 Insider Own2.20% Shs Outstand69.62M Perf Week2.93%
Market Cap2.35B Forward P/E- EPS next Y-1.62 Insider Trans-28.17% Shs Float66.55M Perf Month10.88%
Income-128.00M PEG- EPS next Q-0.56 Inst Own93.01% Short Float4.10% Perf Quarter33.18%
Sales273.40M P/S8.59 EPS this Y14.20% Inst Trans23.16% Short Ratio3.88 Perf Half Y71.34%
Book/sh1.36 P/B24.79 EPS next Y23.20% ROA-43.00% Target Price33.50 Perf Year43.55%
Cash/sh3.42 P/C9.86 EPS next 5Y- ROE-274.00% 52W Range11.08 - 34.53 Perf YTD141.55%
Dividend- P/FCF- EPS past 5Y-21.70% ROI-73.80% 52W High-2.33% Beta1.39
Dividend %- Quick Ratio2.40 Sales past 5Y36.10% Gross Margin37.20% 52W Low204.33% ATR1.48
Employees975 Current Ratio2.50 Sales Q/Q17.90% Oper. Margin-42.90% RSI (14)62.61 Volatility4.48% 4.58%
OptionableYes Debt/Eq1.33 EPS Q/Q23.40% Profit Margin-46.80% Rel Volume1.19 Prev Close33.50
ShortableYes LT Debt/Eq0.79 EarningsAug 07 AMC Payout- Avg Volume702.68K Price33.72
Recom1.80 SMA204.68% SMA5014.58% SMA20057.25% Volume837,950 Change0.66%
Oct-05-18Initiated JP Morgan Neutral $26
Jul-05-18Reiterated Piper Jaffray Overweight $18 → $21
Aug-07-17Reiterated Morgan Stanley Overweight $18 → $13
Nov-10-16Reiterated The Benchmark Company Buy $16 → $20
May-23-16Reiterated The Benchmark Company Buy $15 → $16
May-11-16Reiterated The Benchmark Company Buy $14 → $15
Apr-19-16Initiated The Benchmark Company Buy $14
Sep-28-15Upgrade Wedbush Neutral → Outperform
Aug-14-15Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-04-15Initiated Robert W. Baird Outperform $20
Jul-27-15Initiated Wedbush Neutral $20
Jul-27-15Initiated Piper Jaffray Overweight $24
Jul-27-15Initiated Morgan Stanley Equal-Weight $20
Sep-13-19 11:45AM  CBR® Acquires Evercord Newborn Stem Cell Business from Natera PR Newswire
11:45AM  CBR to Acquire Natera's Evercord Cord Blood Business PR Newswire
Sep-09-19 11:01AM  Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period PR Newswire -7.55%
Sep-05-19 10:06AM  Did Natera, Inc. (NASDAQ:NTRA) Insiders Sell Shares? Simply Wall St.
Sep-04-19 09:03AM  Natera to Present at the Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire
Aug-29-19 09:16AM  Natera Appoints Rowan Chapman to its Board of Directors PR Newswire
Aug-28-19 09:43AM  Natera to Webcast Live Presentation at the Baird 2019 Global Healthcare Conference PR Newswire
Aug-22-19 01:13PM  Medicare Issues Positive Draft Local Coverage Determination for Natera's Signatera MRD Test in Colorectal Cancer PR Newswire
09:16AM  Panorama NIPT Achieves 2 Million Test Milestone PR Newswire
Aug-14-19 06:37AM  Edited Transcript of NTRA earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -7.68%
Aug-12-19 09:15PM  Natera Inc (NTRA) CEO Steven Leonard Chapman Sold $3.3 million of Shares GuruFocus.com -9.48%
Aug-07-19 05:35PM  Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:07PM  Natera Reports Second Quarter 2019 Financial Results PR Newswire
Aug-05-19 08:02AM  Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies PR Newswire -6.28%
Jul-31-19 08:51PM  Natera Announces Second Quarter 2019 Earnings Conference Call PR Newswire
Jul-22-19 02:38PM  Is Natera's (NASDAQ:NTRA) Share Price Gain Of 104% Well Earned? Simply Wall St.
Jul-12-19 05:26PM  Here's Why Natera Stock Soared 97.6% in the First Half of 2019 Motley Fool
Jun-24-19 08:07AM  New ProActive Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients PR Newswire
Jun-19-19 06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
06:00PM  Did Hedge Funds Drop The Ball On Natera Inc (NTRA) ? Insider Monkey
07:27AM  Natera, Inc.'s Shares March Higher, Can It Continue? Zacks
Jun-13-19 07:57PM  Edited Transcript of NTRA earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-06-19 06:59AM  What Kind Of Shareholder Owns Most Natera, Inc. (NASDAQ:NTRA) Stock? Simply Wall St.
Jun-03-19 08:34AM  Data Presented at ASCO Shows Natera's Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers PR Newswire
May-22-19 09:27AM  Natera, Inc. (NTRA) Shares March Higher, Can It Continue? Zacks
May-21-19 09:40AM  Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera Kidney Transplant Test PR Newswire
May-20-19 10:20AM  OncoCyte (OCX) Catches Eye: Stock Jumps 7.3% Zacks
May-10-19 02:24PM  Natera (NTRA) Q1 2019 Earnings Call Transcript Motley Fool +22.25%
May-09-19 07:55PM  Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:49PM  Natera: 1Q Earnings Snapshot Associated Press
04:12PM  Natera Reports First Quarter 2019 Financial Results PR Newswire
12:04PM  New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier PR Newswire
May-07-19 08:27AM  Signatera Blood Test Detects Bladder Cancer Relapse Up to Eight Months Earlier Than Current Clinical Standards PR Newswire
May-06-19 11:55AM  FDA Grants Breakthrough Device Designation to Natera's Signatera Test PR Newswire
May-03-19 08:24PM  Did Hedge Funds Drop The Ball On Natera Inc (NTRA)? Insider Monkey
May-02-19 08:50PM  Natera Announces First Quarter 2019 Earnings Conference Call PR Newswire
Apr-17-19 11:43PM  Natera Announces Pricing of Follow-On Offering PR Newswire -6.40%
07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 04:12PM  Natera Launches Proposed Follow-On Offering PR Newswire
10:13AM  New Publication Validates Clinical Performance of Signatera for Recurrence Monitoring and MRD Assessment in Breast Cancer PR Newswire
Apr-15-19 01:20PM  How Does Natera, Inc. (NASDAQ:NTRA) Affect Your Portfolio Volatility? Simply Wall St.
Apr-10-19 08:03AM  Natera Announces Plans to Commercialize Tumor Whole Exome Sequencing from Plasma PR Newswire
Mar-28-19 12:46PM  Medicare Issues Draft Local Coverage Determination for Natera's New Prospera Kidney Transplant Rejection Test PR Newswire +9.74%
07:15AM  Analysis: Positioning to Benefit within JD, Five9, Ambarella, Natera, Methanex, and Virtusa Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-26-19 08:04AM  Natera to Partner with AMAL Therapeutics on Clinical Trial Using Signatera MRD Test to Assess Treatment Response to Colorectal Cancer Vaccine PR Newswire
Mar-21-19 01:59AM  Edited Transcript of NTRA earnings conference call or presentation 12-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-13-19 01:45PM  Here's Why Natera Rose as Much as 24.7% Today Motley Fool +19.09%
Mar-12-19 08:31PM  Natera Inc (NTRA) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:35PM  After-Hours News: Kraft Heinz and Natera Are Rising Motley Fool
06:05PM  Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates Zacks
05:03PM  Natera: 4Q Earnings Snapshot Associated Press
04:05PM  Natera Reports Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
02:30PM  Natera, Inc. to Host Earnings Call ACCESSWIRE
Mar-11-19 06:03AM  Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq Technology Platform PR Newswire +6.55%
Mar-06-19 04:53PM  /C O R R E C T I O N -- Natera, Inc./ PR Newswire
Mar-05-19 02:17PM  Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call PR Newswire
Feb-27-19 11:11AM  When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? Simply Wall St.
Feb-22-19 09:00AM  Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay PR Newswire
Feb-19-19 01:46PM  Natera Presents Outcomes Data at SMFM Annual Meeting Showing Strong Clinical Performance of Its SNP-Based Non-Invasive Prenatal Test PR Newswire
Feb-01-19 07:30AM  Natera Announces Agreement with One Lambda to Co-Distribute Its Kidney Transplant Rejection Test PR Newswire +5.59%
Jan-22-19 07:30AM  Consolidated Research: 2019 Summary Expectations for Marathon Petroleum, AMC Entertainment, JetBlue Airways, Acceleron Pharma, Natera, and AquaVenture Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-07-19 08:03AM  Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection PR Newswire
Jan-04-19 02:02PM  Natera To Webcast Live Presentation at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire
08:03AM  Natera Obtains Z-Codes for Signatera MRD and Treatment Monitoring Test in Oncology PR Newswire
Jan-02-19 04:02PM  Natera Appoints Steve Chapman CEO and Robert Schueren COO; Matthew Rabinowitz Moves to Executive Chairman PR Newswire -7.23%
Dec-25-18 10:14AM  Who Has Been Selling Natera, Inc. (NASDAQ:NTRA) Shares? Simply Wall St.
Dec-14-18 10:11PM  Is Natera Inc (NTRA) Going to Burn These Hedge Funds? Insider Monkey -7.27%
Dec-06-18 08:03AM  Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response PR Newswire
Nov-29-18 08:04AM  Natera Achieves Enrollment Goal of 20,000 Patients in SMART Study PR Newswire
Nov-28-18 08:25AM  New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire +9.94%
08:03AM  Natera Receives Unique Z-Code for Its Kidney Transplant Rejection Monitoring Test PR Newswire
Nov-27-18 08:06AM  PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects Zacks
Nov-14-18 07:42AM  Edited Transcript of NTRA earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-09-18 01:01PM  Earnings Results Make 3 Stocks Move Friday GuruFocus.com -18.57%
Nov-08-18 06:15PM  Natera (NTRA) Reports Q3 Loss, Misses Revenue Estimates Zacks
05:16PM  Natera: 3Q Earnings Snapshot Associated Press
04:05PM  Natera Reports Third Quarter 2018 Financial Results PR Newswire
Nov-01-18 11:00AM  Natera Announces Third Quarter 2018 Earnings Conference Call PR Newswire
Oct-31-18 05:35PM  Premier Bay Area biotech developer tees up next major project American City Business Journals +5.73%
Oct-18-18 04:20PM  Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine GlobeNewswire
07:25AM  Report: Developing Opportunities within Natera, InnerWorkings, Chanticleer, NN, Stoneridge, and Avid Technology Future Expectations, Projections Moving into 2018 GlobeNewswire
Sep-26-18 08:15PM  Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $8.1 million of Shares GuruFocus.com
Sep-21-18 07:15PM  Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $5.1 million of Shares GuruFocus.com
Sep-19-18 10:13AM  Have Investors Priced In Healthcare Growth For Natera Inc (NASDAQ:NTRA)? Simply Wall St.
Sep-18-18 07:15PM  Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $6.1 million of Shares GuruFocus.com
Sep-13-18 08:15PM  Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $10 million of Shares GuruFocus.com
01:02PM  Natera Signs Agreement with Bristol-Myers Squibb to Investigate Signatera ctDNA Assay as a Potential Biomarker for Opdivo (nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial PR Newswire
Aug-24-18 07:45AM  Detailed Research: Economic Perspectives on New Mountain Finance, Myers Industries, Pilgrim's Pride, Natera, Francesca's, and Synaptics What Drives Growth in Today's Competitive Landscape GlobeNewswire
Aug-22-18 09:28AM  Why this developer who's a tech CEO by day sees San Carlos as fertile ground for new housing American City Business Journals
Aug-20-18 07:50PM  Edited Transcript of NTRA earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-17-18 03:16PM  GOLD PR | Social Media Named to the 2018 Inc. 5000 List of America's Fastest-Growing Private Companies PR Newswire
Aug-15-18 12:41PM  Natera and Fox Chase Cancer Center to Collaborate on Kidney Cancer Study PR Newswire
Aug-08-18 06:25PM  Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:24PM  Natera: 2Q Earnings Snapshot Associated Press
04:10PM  Natera Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  Natera, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 02:50PM  Natera Clinical Study Validates New Biomarker for Aneuploidy and Adverse Pregnancy Outcomes PR Newswire
Aug-02-18 08:06AM  Study Shows Natera's Spectrum Preimplantation Genetic Testing for Aneuploidy Improves IVF Outcomes for All Women, Regardless of Maternal Age PR Newswire
Jul-31-18 11:00AM  Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience PR Newswire
Jul-16-18 09:32AM  Can The Uptrend Continue for Natera (NTRA)? Zacks +5.42%
Natera, Inc., a diagnostics company, provides preconception and prenatal genetic testing services. It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the carrier's children; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora products of conception test to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Evercord, a cord blood and cord tissue processing and storage service; and Signatera, a circulating tumor DNA technology that analyzes and tracks mutations to an individual's tumor. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners in the United States and internationally. Natera, Inc. has research collaborations with the Institut Jules Bordet and Fox Chase Cancer Center. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sheena JonathanChief Technology OfficerSep 10Sale29.501,03330,469240,904Sep 11 04:41 PM
Brophy Michael BurkesChief Financial OfficerSep 10Sale29.501,20635,57216,005Sep 11 04:41 PM
Chapman Steven LeonardChief Executive OfficerSep 10Sale29.501,15534,0683,370Sep 11 04:40 PM
Rabinowitz MatthewExecutive ChairmanSep 10Sale29.501,41741,7961,286,747Sep 11 04:40 PM
Brophy Michael BurkesChief Financial OfficerSep 04Option Exercise9.487873914,268Sep 06 04:56 PM
Brophy Michael BurkesChief Financial OfficerSep 04Sale32.49782,53414,190Sep 06 04:56 PM
Brophy Michael BurkesChief Financial OfficerAug 30Option Exercise10.083,48435,10617,674Sep 03 05:35 PM
Brophy Michael BurkesChief Financial OfficerAug 30Sale32.973,484114,86714,190Sep 03 05:35 PM
Chapman Steven LeonardChief Executive OfficerAug 09Option Exercise9.6991,373885,815101,225Aug 12 06:32 PM
Sheena JonathanChief Technology OfficerAug 09Option Exercise2.66125,000332,113364,645Aug 12 06:33 PM
Sheena JonathanChief Technology OfficerAug 09Sale32.59125,0004,074,227239,645Aug 12 06:33 PM
Chapman Steven LeonardChief Executive OfficerAug 09Sale33.0098,9963,266,8682,229Aug 12 06:32 PM
Sheena JonathanChief Technology OfficerAug 08Option Exercise2.66125,000332,113364,645Aug 12 06:33 PM
Brophy Michael BurkesChief Financial OfficerAug 08Option Exercise10.0243,954440,29958,144Aug 12 06:33 PM
Brophy Michael BurkesChief Financial OfficerAug 08Sale29.0043,9541,274,66614,190Aug 12 06:33 PM
Sheena JonathanChief Technology OfficerAug 08Sale30.14125,0003,767,547239,645Aug 12 06:33 PM
Rabinowitz MatthewExecutive ChairmanJul 15Sale25.841543,9791,285,346Jul 16 04:41 PM
Brophy Michael BurkesChief Financial OfficerJun 24Sale25.192756,92714,190Jun 25 04:46 PM
Chapman Steven LeonardChief Executive OfficerJun 24Sale25.193909,8249,852Jun 25 04:46 PM
Sheena JonathanChief Technology OfficerJun 24Sale25.1950012,595239,645Jun 25 04:46 PM
Rabinowitz MatthewExecutive ChairmanJun 10Sale24.791,41835,1541,285,194Jun 11 04:45 PM
Chapman Steven LeonardChief Executive OfficerJun 10Sale24.7979419,6849,125Jun 11 04:46 PM
Brophy Michael BurkesChief Financial OfficerJun 10Sale24.7974718,51913,348Jun 11 04:44 PM
Sheena JonathanChief Technology OfficerJun 10Sale24.791,03325,610239,028Jun 11 04:43 PM
Rabinowitz MatthewExecutive ChairmanApr 15Sale20.2561412,4341,283,794Apr 16 09:28 PM
Sheena JonathanChief Technology OfficerMar 29Option Exercise2.662,6206,961240,390Apr 02 04:51 PM
Sheena JonathanChief Technology OfficerMar 29Sale20.502,62053,710237,770Apr 02 04:51 PM
Sheena JonathanChief Technology OfficerMar 22Sale20.2050610,221237,770Mar 22 08:09 PM
Brophy Michael BurkesChief Financial OfficerMar 22Sale20.202735,51411,075Mar 25 08:10 PM
Chapman Steven LeonardChief Executive OfficerMar 22Sale20.203847,7577,623Mar 25 08:11 PM
Sheena JonathanChief Technology OfficerMar 21Option Exercise2.6671,317189,482308,475Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 21Sale20.5071,3171,462,006237,158Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 20Option Exercise2.66118,463314,744355,621Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 20Sale20.50118,4632,428,515237,158Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 13Option Exercise2.6657,600153,037294,758Mar 15 05:15 PM
Sheena JonathanChief Technology OfficerMar 13Sale20.5123,356478,997271,402Mar 15 05:15 PM
Chapman Steven LeonardChief Operating OfficerMar 11Sale16.003,41054,5726,889Mar 12 05:17 PM
Rabinowitz MatthewExecutive ChairmanMar 11Sale16.005,67290,7711,283,181Mar 12 05:16 PM
Sheena JonathanChief Technology OfficerMar 11Sale16.003,04348,698237,158Mar 12 05:14 PM
Brophy Michael BurkesChief Financial OfficerMar 11Sale16.003,19251,08310,230Mar 12 05:12 PM
Rabinowitz MatthewExecutive ChairmanJan 08Option Exercise0.84665,237558,9181,277,581Jan 09 06:06 AM
Chapman Steven LeonardChief Operating OfficerDec 24Sale12.395657,0011,114Dec 26 04:15 PM
Brophy Michael BurkesChief Financial OfficerDec 24Sale12.394495,5631,339Dec 26 04:15 PM
Sheena JonathanChief Technology OfficerDec 24Sale12.395076,282231,035Dec 26 04:15 PM
Sheena JonathanChief Technology OfficerOct 16Option Exercise1.1416,27618,571312,696Oct 17 07:26 PM
Sheena JonathanChief Technology OfficerOct 16Sale21.0682,2711,732,465230,425Oct 17 07:26 PM
Sheena JonathanChief Technology OfficerOct 15Option Exercise1.5133,72450,959380,816Oct 17 07:26 PM
Sheena JonathanChief Technology OfficerOct 15Sale20.2884,3961,711,514296,420Oct 17 07:26 PM
Chapman Steven LeonardChief Operating OfficerOct 12Option Exercise10.5135,000367,97335,562Oct 15 05:54 PM
Chapman Steven LeonardChief Operating OfficerOct 12Sale20.6635,000723,195562Oct 15 05:54 PM
Chapman Steven LeonardChief Operating OfficerOct 02Option Exercise9.9835,000349,21335,562Oct 04 04:59 PM
Chapman Steven LeonardChief Operating OfficerOct 02Sale23.7635,000831,611562Oct 04 04:59 PM
Rabinowitz MatthewChief Executive OfficerSep 27Sale22.8481,0991,852,499612,344Oct 01 05:16 PM
Chapman Steven LeonardChief Operating OfficerSep 26Option Exercise9.596,00057,5409,762Sep 28 04:16 PM
Rabinowitz MatthewChief Executive OfficerSep 26Sale24.84139,0893,455,374693,443Sep 26 05:33 PM
Chapman Steven LeonardChief Operating OfficerSep 26Sale24.889,200228,870562Sep 28 04:16 PM
Rabinowitz MatthewChief Executive OfficerSep 25Sale25.06149,9103,756,630832,532Sep 26 05:33 PM
Rabinowitz MatthewChief Executive OfficerSep 24Sale23.9835,845859,466982,442Sep 26 05:33 PM
Brophy Michael BurkesChief Financial OfficerSep 24Sale23.7844610,606671Sep 25 07:16 PM
Chapman Steven LeonardChief Operating OfficerSep 24Sale23.7856213,3643,762Sep 25 07:17 PM
Sheena JonathanChief Technology OfficerSep 24Sale23.783247,704347,092Sep 25 07:16 PM
open in yahoo | open in reuters | open in google